Point72

Total investments

21

Average round size

68M

Portfolio companies

19

Rounds per year

1.75

Follow on index

0.10

Exits

4

Areas of investment
BiotechnologySoftwareFinancial ServicesFinTechHuman ResourcesHealth CareHealth DiagnosticsManufacturingPharmaceuticalTherapeutics

Investments analytics

Analytics

Total investments
21
Lead investments
0
Exits
4
Rounds per year
1.75
Follow on index
0.10
Investments by industry
  • Biotechnology (11)
  • Software (4)
  • Pharmaceutical (4)
  • Therapeutics (4)
  • Health Care (3)
  • Show 27 more
Investments by region
  • United States (18)
  • United Kingdom (1)
  • Israel (1)
Peak activity year
2021
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
86M
Group Appearance index
0.95
Avg. company exit year
14
Avg. multiplicator
0.55
Strategy success index
0.70

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Arch Oncology 27 Apr 2021 Biotechnology Late Stage Venture 105M United States, California
ioranges Automation 02 Nov 2015 Artificial Intelligence, Robotics Seed 0 China, Guangdong Province, Futian District
SiMa.ai 04 Apr 2024 Software, Artificial Intelligence, Machine Learning Late Stage Venture 70M United States, California, San Jose
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.